# A Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body Weight

> **NCT07357766** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Novo Nordisk A/S** · enrollment: 1400 (estimated)

## Conditions studied

- Overweight
- Obesity

## Interventions

- **DRUG:** Cagrisema
- **DRUG:** Placebo CagriSema

## Key facts

- **NCT ID:** NCT07357766
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-22
- **Primary completion:** 2027-11-29
- **Final completion:** 2028-01-17
- **Target enrollment:** 1400 (ESTIMATED)
- **Last updated:** 2026-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07357766

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07357766, "A Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body Weight". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07357766. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*